8.74 -0.05 (-0.57%)
4:00 PM ET 12/07/09
Company Profile
Price and Volume
Recent Price 8.74
52 Week High 14.75
52 Week Low 4.19
Avg. Daily Vol. (Mil) 0.83
Beta (3 year) 1.82
Share Related Items
Mkt Cap (Mil) 452.92
Shares Out (Mil) 51.82
Float (Mil) 36.48
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 7.70
Current Ratio 7.80
LT Debt/ Equity 0.01
Total Debt / Equity 0.02
Valuation Ratios
Price Earnings n.a.
Price/Sales 0.00
Price/Book 3.48
Price/Cash Flow -3.80
Per Share Data
Earnings -3.24
Sales 0.00
Book Value 2.51
Cash Flow -2.28
Business Summary
A clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory/autoimmune diseases, as well as for certain cancers and metabolic diseases.
General Information
1180 Veterans Blvd.
South San Francisc, CA 94080
www.rigel.com
Industry : Drugs
Sector: Health Care
Employees: 181
CEO: James M. Gower
Short Interest
Current Month (Mil) 4.49
Previous Month (Mil) 3.66
Short Interest Ratio (Days) 5.80
Management Effectiveness
Return on Equity n.a.
Return on Assets -72.90
Return on Investments -91.00
Profitability
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00
Dow Jones S&P 500 NASDAQ 10-Year Note
10,390.11 1,103.25 2,189.61 34.48
Oil *
75.70
UP
1.21
DOWN
2.73
DOWN
4.74
DOWN
0.35
10 Yr
3.45%
SPDR Gold
113.11
+0.01%
-0.25%
-0.22%
-1.00%
Data delayed 20 minutes

Brokerage Partners

TheStreet Premium Services

All Services